Main Street Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52K Sell
503
-19
-4% -$1.7K 0.01% 258
2026
Q1
$37.5K Buy
+522
New +$40.2K 0.01% 311
2025
Q4
Sell
-522
Closed -$39.4K 206
2025
Q3
$39.4K Sell
522
-800
-61% -$54.8K 0.01% 285
2025
Q2
$91.2K Sell
1,322
-64
-5% -$4.2K 0.03% 168
2025
Q1
$93.9K Buy
1,386
+64
+5% +$3.83K 0.04% 161
2024
Q4
$59.3K Buy
1,322
+284
+27% +$15.9K 0.02% 210
2024
Q3
$65.3K Sell
1,038
-800
-44% -$46.7K 0.03% 209
2024
Q2
$107K Sell
1,838
-1,650
-47% -$103K 0.04% 162
2024
Q1
$278K Buy
3,488
+2,712
+349% +$207K 0.12% 84
2023
Q4
$61.3K Buy
+776
New +$55.2K 0.02% 345

Other funds holding CVS

Main Street Group's CVS Position: Q2 2026 in Review

Main Street Group reduced its CVS Health (CVS) stake by 3.6% in Q2 2026, selling an estimated $1.7K and leaving 503 shares worth $52K. The position accounts for 0.01% of the portfolio, ranked #258.

Main Street Group first reported a position in CVS in Q4 2023 and has held it in 10 quarters since. The position peaked at $278K in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Main Street Group held 503 shares of CVS Health worth $52K as of Q2 2026.
  • Main Street Group sold 19 CVS Health shares in Q2 2026, an estimated $1.7K.
  • CVS Health made up 0.01% of Main Street Group's portfolio in Q2 2026, its #258 holding.
  • Main Street Group first reported a position in CVS Health in Q4 2023 and has held it in 10 quarters since.
  • Main Street Group's CVS Health position peaked at $278K in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.